Abstract
To obtain high yields of toxin for the preparation of purified neurotoxoids, we examined the time of appearance and the quantity of toxin produced by the Bean strain of Clostridium botulinum type B under various conditions by using a fermentor system. The medium employed consisted of 2.0% casein hydrolylsate and 1.5% yeast extract plus an appropriate concentration of glucose. The maximum toxin concentration (4 x 10(5) to 5 x 10(5) mouse median lethal doses per ml) was attained within 48 h under the following fermentation conditions: an initial glucose concentration of 0.5 or 1.0%, a temperature of 35 degrees C, a nitrogen overlay at a rate of 5 liters/min, and an agitation rate of 50 rpm.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Beers W. H., Reich E. Isolation and characterization of Clostridium botulinum type B toxin. J Biol Chem. 1969 Aug 25;244(16):4473–4479. [PubMed] [Google Scholar]
- Boroff D. A., Meloche H. P., Dasgupta B. R. Amino Acid Analysis of the Isolated and Purified Components from Crystalline Toxin of Clostridium botulinum Type A. Infect Immun. 1970 Nov;2(5):679–680. doi: 10.1128/iai.2.5.679-680.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DUFF J. T., KLERER J., BIBLER R. H., MOORE D. E., GOTTFRIED C., WRIGHT G. G. Studies on immunity to toxins of Clostridium botulinum. II. Production and purification of type B toxin for toxoid. J Bacteriol. 1957 May;73(5):597–601. doi: 10.1128/jb.73.5.597-601.1957. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dasgupta B. R., Sugiyama H. Molecular forms of neurotoxins in proteolytic Clostridium botulinum type B cultures. Infect Immun. 1976 Sep;14(3):680–686. doi: 10.1128/iai.14.3.680-686.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FIOCK M. A., CARDELLA M. A., GEARINGER N. F. STUDIES ON IMMUNITY TO TOXINS OF CLOSTRIDIUM BOTULINUM. IX. IMMUNOLOGIC RESPONSE OF MAN TO PURIFIED PENTAVALENT ABCDE BOTULINUM TOXIOD. J Immunol. 1963 May;90:697–702. [PubMed] [Google Scholar]
- Lamanna C., Glassman H. N. The Isolation of Type B Botulinum Toxin. J Bacteriol. 1947 Nov;54(5):575–584. doi: 10.1128/jb.54.5.575-584.1947. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Metzger J. F., Lewis G. E., Jr Human-derived immune globulins for the treatment of botulism. Rev Infect Dis. 1979 Jul-Aug;1(4):689–692. doi: 10.1093/clinids/1.4.689. [DOI] [PubMed] [Google Scholar]
- Siegel L. S., Metzger J. F. Toxin production by Clostridium botulinum type A under various fermentation conditions. Appl Environ Microbiol. 1979 Oct;38(4):606–611. doi: 10.1128/aem.38.4.606-611.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]